{"entity":{"type":"insider","cik":"0001564380","url":"/insider/0001564380","json_url":"/insider/0001564380.json","name":"Kinney Gene G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":14,"first":"2014-05-12","last":"2023-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Kinney Gene G.","source":"filing","n_filings":14,"first_seen":"2014-05-12","last_seen":"2023-05-17"}],"transactions":[{"id":8260179,"accession":"0001140361-23-025344","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-23-025344","line_url":"/filing/0001140361-23-025344","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":73.6953739111111,"price_display":"73.70","price_state":"stated","total_value":3316291.826,"total_display":"3,316,291.83","total_whole":"3,316,292","shares_owned_after":27727.0,"shares_owned_after_display":"27,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-17","scope":"insider","n_lines":3},{"id":6667164,"accession":"0001140361-22-035564","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001140361-22-035564","line_url":"/filing/0001140361-22-035564","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16412.0,"shares_display":"16,412","price_per_share":53.37605414330977,"price_display":"53.38","price_state":"stated","total_value":876007.8006,"total_display":"876,007.80","total_whole":"876,008","shares_owned_after":19295.0,"shares_owned_after_display":"19,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-30","scope":"insider","n_lines":10},{"id":6964361,"accession":"0001140361-22-034588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-034588","line_url":"/filing/0001140361-22-034588#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2720.0,"shares_display":"2,720","price_per_share":32.0183,"price_display":"32.02","price_state":"stated","total_value":87089.776,"total_display":"87,089.78","total_whole":"87,090","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider"},{"id":6609030,"accession":"0001567619-22-016512","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-016512","line_url":"/filing/0001567619-22-016512#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2181.0,"shares_display":"2,181","price_per_share":32.0287,"price_display":"32.03","price_state":"stated","total_value":69854.5947,"total_display":"69,854.59","total_whole":"69,855","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":6218570,"accession":"0001140361-22-029517","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-22-029517","line_url":"/filing/0001140361-22-029517#line-6","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20284.0,"shares_display":"20,284","price_per_share":32.1579,"price_display":"32.16","price_state":"stated","total_value":652290.8436,"total_display":"652,290.84","total_whole":"652,291","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2022-08-12","scope":"insider"},{"id":6218563,"accession":"0001140361-22-029517","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-22-029517","line_url":"/filing/0001140361-22-029517#line-4","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13650.0,"shares_display":"13,650","price_per_share":32.1561,"price_display":"32.16","price_state":"stated","total_value":438930.765,"total_display":"438,930.76","total_whole":"438,931","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-12","scope":"insider"},{"id":6218556,"accession":"0001140361-22-029517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-029517","line_url":"/filing/0001140361-22-029517#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":991.0,"shares_display":"991","price_per_share":32.0118,"price_display":"32.01","price_state":"stated","total_value":31723.6938,"total_display":"31,723.69","total_whole":"31,724","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"},{"id":6255747,"accession":"0001567619-22-015086","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-22-015086","line_url":"/filing/0001567619-22-015086","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21506.0,"shares_display":"21,506","price_per_share":32.83099113735702,"price_display":"32.83","price_state":"stated","total_value":706063.2954,"total_display":"706,063.30","total_whole":"706,063","shares_owned_after":17466.0,"shares_owned_after_display":"17,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-05","scope":"insider","n_lines":2},{"id":6255740,"accession":"0001567619-22-015086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-015086","line_url":"/filing/0001567619-22-015086#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20954.0,"shares_display":"20,954","price_per_share":32.1808,"price_display":"32.18","price_state":"stated","total_value":674316.4832,"total_display":"674,316.48","total_whole":"674,316","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6240967,"accession":"0001140361-22-027528","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-027528","line_url":"/filing/0001140361-22-027528#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"PROTHENA CORP PUBLIC LTD CO","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":376.0,"shares_display":"376","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":12032.0,"total_display":"12,032.00","total_whole":"12,032","shares_owned_after":12793.0,"shares_owned_after_display":"12,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-29","scope":"insider"},{"id":4886771,"accession":"0000899243-17-022967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-022967","line_url":"/filing/0000899243-17-022967#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":196000.0,"total_display":"196,000.00","total_whole":"196,000","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-28","filed_date":"2017-09-29","scope":"insider"},{"id":4728594,"accession":"0000899243-17-006338","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-006338","line_url":"/filing/0000899243-17-006338","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25163.0,"shares_display":"25,163","price_per_share":60.773673465008144,"price_display":"60.77","price_state":"stated","total_value":1529247.9454,"total_display":"1,529,247.95","total_whole":"1,529,248","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider","n_lines":2},{"id":4522917,"accession":"0000899243-17-006027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-006027","line_url":"/filing/0000899243-17-006027#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3796.0,"shares_display":"3,796","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":227760.0,"total_display":"227,760.00","total_whole":"227,760","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-02","scope":"insider"},{"id":3200090,"accession":"0000899243-16-033196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-033196","line_url":"/filing/0000899243-16-033196#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8548.0,"shares_display":"8,548","price_per_share":55.3235,"price_display":"55.32","price_state":"stated","total_value":472905.278,"total_display":"472,905.28","total_whole":"472,905","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-10","scope":"insider"},{"id":3274411,"accession":"0000899243-16-032172","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-16-032172","line_url":"/filing/0000899243-16-032172#line-4","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5834.0,"shares_display":"5,834","price_per_share":55.15,"price_display":"55.15","price_state":"stated","total_value":321745.1,"total_display":"321,745.10","total_whole":"321,745","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-21","filed_date":"2016-10-21","scope":"insider"},{"id":3274405,"accession":"0000899243-16-032172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-032172","line_url":"/filing/0000899243-16-032172#line-2","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14785.0,"shares_display":"14,785","price_per_share":55.08,"price_display":"55.08","price_state":"stated","total_value":814357.8,"total_display":"814,357.80","total_whole":"814,358","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-21","scope":"insider"},{"id":8170549,"accession":"0000899243-15-009696","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-15-009696","line_url":"/filing/0000899243-15-009696","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (CSO & Head of R&D)","role_mark":"O","role_mark_label":"Officer (CSO & Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & Head of R&D","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":66.15421257333334,"price_display":"66.15","price_state":"stated","total_value":1984626.3772,"total_display":"1,984,626.38","total_whole":"1,984,626","shares_owned_after":4153.0,"shares_owned_after_display":"4,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-11","scope":"insider","n_lines":3},{"id":6971797,"accession":"0001209191-14-033068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-033068","line_url":"/filing/0001209191-14-033068#line-1","is_derivative":false,"issuer_cik":"0001559053","issuer_name":"Prothena Corp plc","issuer_ticker":"PRTA","issuer_name_source":null,"issuer_url":"/issuer/0001559053","owner_cik":"0001564380","owner_name":"Kinney Gene G.","owner_display_name":"Kinney Gene G.","owner_url":"/insider/0001564380","role":"Officer (CSO & Head of R&D)","role_mark":"O","role_mark_label":"Officer (CSO & Head of R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & Head of R&D","security_title":"Ordinary Shares, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":19.5399,"price_display":"19.54","price_state":"stated","total_value":48849.75,"total_display":"48,849.75","total_whole":"48,850","shares_owned_after":2793.0,"shares_owned_after_display":"2,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001559053","name":"PROTHENA CORP PUBLIC LTD CO","url":"/issuer/0001559053","role":"Director, Officer (President and CEO)","n_filings":14,"first_seen":"2014-05-12","last_seen":"2023-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001564380","retrieved_at":"2026-08-27T11:11:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}